Not applicableApproved For MarketingNCT04914247
What this trial is testing
Individual Patient Expanded Access IND for Selexipag (Uptravi) in Participants With Non-healing Wound, Buerger's Disease
Who this might be right for
Non-healing WoundThromboangiitis Obliterans
Actelion